Partner With
Constructive Bio.
Many promising biologics languish not because they cannot be imagined but because they cannot be manufactured. Constructive works with partners to change that.
Collaboration models
Discovery and design collaborations
Applying expanded chemistry to explore new molecular architectures, improved pharmacology and enabling protein functions.
Joint therapeutic development
Advancing peptide and protein therapeutic programmes where expanded chemistry provides a clear pharmacological, functional or manufacturing advantage.
Manufacturing enablement
Developing scalable production strategies for complex peptides and proteins that challenge traditional synthesis.
Partnership opportunities
Pharmaceutical Partnerships
We enable our partners to discover and create improved therapeutic molecules across diverse modalities while maintaining scalable manufacturing, for example:
- Next-generation therapeutic peptides
- Site-specific drug conjugates
- Engineered cytokines and immune modulators
- Enhanced versions of established biologics such as GLP-1 analogues
BioForge Collaborations
BioForge provides a manufacturing pathway for molecular designs that challenge traditional peptide synthesis or natural expression systems.
- Enabling scalable production for advanced protein designs
- Integrating expanded chemistry into protein engineering platforms
- Joint development and manufacture of new therapeutic modalities
Industrial & Materials Partnerships
Expanded chemistry opens opportunities for industrial partners beyond medicine and across the bioeconomy.
- Advanced protein-based materials
- Specialty biomolecules and polymers
- Sustainable production through fermentation
Our Team Works Closely With You
From molecular concept to manufacturable molecule, Constructive’s team guides every stage of the collaboration.
- Rapid feasibility assessment for your target molecule
- Collaborative program design and milestones
- Direct access to our science and manufacturing teams
Explore a partnership
Constructive Bio works with partners to design, create and biomanufacture novel, patentable peptide and protein-based therapeutics. Our ability to tune, enhance and enable biotherapeutic molecules through ncAA incorporation enables improved biologics beyond the reach of traditional chemistries, and we do so with a sustainable, scalable and cost-effective biomanufacturing focus.
